These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10864211)

  • 1. Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.
    Karjalainen JM; Kellokoski JK; Mannermaa AJ; Kujala HE; Moisio KI; Mitchell PJ; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 2000 Jun; 82(12):2015-21. PubMed ID: 10864211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.
    Anttila MA; Kellokoski JK; Moisio KI; Mitchell PJ; Saarikoski S; Syrjänen K; Kosma VM
    Br J Cancer; 2000 Jun; 82(12):1974-83. PubMed ID: 10864206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
    Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.
    Shirasaki F; Takata M; Hatta N; Takehara K
    Cancer Res; 2001 Oct; 61(20):7422-5. PubMed ID: 11606374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes.
    Takahashi H; Oyama N; Itoh Y; Ishida-Yamamoto A; Kaneko F; Iizuka H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):719-23. PubMed ID: 11095974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
    Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
    Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.
    Fauquette V; Aubert S; Groux-Degroote S; Hemon B; Porchet N; Van Seuningen I; Pigny P
    Carcinogenesis; 2007 Nov; 28(11):2305-12. PubMed ID: 17621592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and regulation of tissue-specific cis-acting elements associated with the human AP-2alpha gene.
    Zhang J; Williams T
    Dev Dyn; 2003 Oct; 228(2):194-207. PubMed ID: 14517991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
    Gee JM; Robertson JF; Ellis IO; Nicholson RI; Hurst HC
    J Pathol; 1999 Dec; 189(4):514-20. PubMed ID: 10629551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor AP-2alpha triggers apoptosis in cardiac myocytes.
    Müller FU; Loser K; Kleideiter U; Neumann J; von Wallbrunn C; Dobner T; Scheld HH; Bantel H; Engels IH; Schulze-Osthoff K; Schmitz W
    Cell Death Differ; 2004 May; 11(5):485-93. PubMed ID: 14752511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
    Ropponen KM; Kellokoski JK; Pirinen RT; Moisio KI; Eskelinen MJ; Alhava EM; Kosma VM
    J Clin Pathol; 2001 Jul; 54(7):533-8. PubMed ID: 11429425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
    Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
    Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.